171 related articles for article (PubMed ID: 31713108)
1. Tigecycline-induced coagulopathy: a literature review.
Cui N; Cai H; Li Z; Lu Y; Wang G; Lu A
Int J Clin Pharm; 2019 Dec; 41(6):1408-1413. PubMed ID: 31713108
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for tigecycline-induced hypofibrinogenaemia.
Zhang Q; Wang J; Liu H; Ma W; Zhou S; Zhou J
J Clin Pharm Ther; 2020 Dec; 45(6):1434-1441. PubMed ID: 32860258
[TBL] [Abstract][Full Text] [Related]
3. A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia.
Wu X; Zhao P; Dong L; Zhang X
Medicine (Baltimore); 2017 Dec; 96(49):e9124. PubMed ID: 29245350
[TBL] [Abstract][Full Text] [Related]
4. Tigecycline-Associated Coagulopathy: A Single-Center Retrospective Analysis.
Wang D; Lin C; Gu C; Wu Y; Wang S
Pharmacology; 2022; 107(9-10):524-536. PubMed ID: 35820375
[TBL] [Abstract][Full Text] [Related]
5. Tigecycline-associated hypofibrinogenemia in a real-world setting.
Campany-Herrero D; Larrosa-Garcia M; Lalueza-Broto P; Rivera-Sánchez L; Espinosa-Pereiro J; Mestre-Torres J; Pigrau-Serrallach C
Int J Clin Pharm; 2020 Aug; 42(4):1184-1189. PubMed ID: 32504166
[TBL] [Abstract][Full Text] [Related]
6. Hypofibrinogenemia induced by high-dose tigecycline-case report and review of literature.
Fan Q; Huang W; Weng Y; Xie X; Shi Z
Medicine (Baltimore); 2020 Oct; 99(43):e22638. PubMed ID: 33120753
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Analysis of the Effect of Tigecycline on Coagulation Function.
Leng B; Xue YC; Zhang W; Gao TT; Yan GQ; Tang H
Chem Pharm Bull (Tokyo); 2019; 67(3):258-264. PubMed ID: 30828002
[TBL] [Abstract][Full Text] [Related]
8. Tigecycline-induced coagulopathy.
McMahan J; Moenster RP
Am J Health Syst Pharm; 2017 Feb; 74(3):130-134. PubMed ID: 28122754
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical characteristics of tigecycline-induced acute pancreatitis.
Fang W; Yi D; Sun L; Wang C
J Clin Pharm Ther; 2020 Dec; 45(6):1320-1324. PubMed ID: 32649800
[TBL] [Abstract][Full Text] [Related]
10. Tigecycline-induced life-threatening coagulopathy in a patient with a Mycobacterium abscess: a case report and step-by-step diagnostic approach.
Akalay S; Vanassche T; De Munter P
Acta Clin Belg; 2021 Oct; 76(5):410-414. PubMed ID: 32255411
[TBL] [Abstract][Full Text] [Related]
11. Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database.
Guo M; Liang J; Li D; Zhao Y; Xu W; Wang L; Cui X
Thromb J; 2022 Mar; 20(1):12. PubMed ID: 35248072
[TBL] [Abstract][Full Text] [Related]
12. Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis.
Rossitto G; Piano S; Rosi S; Simioni P; Angeli P
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):681-4. PubMed ID: 24667348
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.
Hu J; Xiao YH; Zheng Y; Lai YX; Fang XL; Fang Q
Eur J Clin Pharmacol; 2020 Jul; 76(7):913-922. PubMed ID: 32355990
[TBL] [Abstract][Full Text] [Related]
14. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder.
Sabanis N; Paschou E; Gavriilaki E; Kalaitzoglou A; Vasileiou S
Infect Dis (Lond); 2015; 47(10):743-6. PubMed ID: 25951751
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis.
Zha L; Pan L; Guo J; French N; Villanueva EV; Tefsen B
Adv Ther; 2020 Mar; 37(3):1049-1064. PubMed ID: 32006240
[TBL] [Abstract][Full Text] [Related]
16. High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections.
Routsi C; Kokkoris S; Douka E; Ekonomidou F; Karaiskos I; Giamarellou H
Int J Antimicrob Agents; 2015 Jan; 45(1):90-3. PubMed ID: 25241261
[No Abstract] [Full Text] [Related]
17. Tigecycline treatment causes a decrease in fibrinogen levels.
Zhang Q; Zhou S; Zhou J
Antimicrob Agents Chemother; 2015 Mar; 59(3):1650-5. PubMed ID: 25547356
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Nomogram for Predicting Tigecycline-Related Coagulopathy: A Retrospective Cohort Study.
Li Z; Zeng Q; Xu S; Li Y; Tang T; Shi J; Song X; He W; Chen L; Liu G; Gao B; Zheng J; Huang L; Chen M; Jiang S
Infect Drug Resist; 2023; 16():423-434. PubMed ID: 36718461
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline Interferes with Fibrinogen Polymerization Independent of Peripheral Interactions with the Coagulation System.
Brandtner A; Bachler M; Fries D; Hermann M; Ruehlicke J; Fux V; Griesmacher A; Niederwanger C; Hell T; Treml B
Antibiotics (Basel); 2020 Feb; 9(2):. PubMed ID: 32074981
[TBL] [Abstract][Full Text] [Related]
20. Acute liver failure caused by high-dose tigecycline: A case report.
Zhang Y; Wang J; Tan Y; Wu J
Int J Clin Pharmacol Ther; 2024 Jul; 62(7):339-344. PubMed ID: 38606856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
